Sign in

NCT05776654Completed

Wearable Devices in the Recovery Phase of Acute Exacerbations of COPD (AECOPDs)

Characterizing the Recovery Phase of Acute Exacerbations of COPD Using Wearable Remote Monitoring Technology

Source: ClinicalTrials.gov · Last updated 29 May 2024

Brief summary (registry, in English)

The purpose the study is to successfully characterize the recovery phase of acute exacerbations of COPD in the outpatient setting using remotely captured physiologic data from wearable devices, to compare this with patient self-reported symptom data, to determine which physiologic variable(s) best correspond with AECOPD recovery, and to further document the feasibility, data quantity, data quality, and COPD outpatient usability experience with wearable devices.

Status (registry)
Completed
Study type
Observational
Enrollment
21 (actual)
First submitted
16 Feb 2023
Start date
16 Feb 2023
Primary completion date
15 Jan 2024
Lead sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Diseases
COPD
NCT number
NCT05776654

What you commit to

  • Study type: Observational
  • Participants enrolled: 21
  • From 16 Feb 2023 to the primary completion date, 15 Jan 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Have already received 4 or more days of consecutive corticosteroid and/or antibiotic therapy since presenting to medical attention for their AECOPD

Other illness

  • History of cardiac arrhythmia
  • Any medical/cognitive/functional condition which renders inability to don/doff/recharge devices and complete symptom questionnaire

Other

  • No existing COPD diagnosis
  • Presence of pacemaker/defibrillator

Who the study is looking for

  • Males/females, age ≥40, former/current smokers with ≥10 pack-year smoking history
  • Currently experiencing/receiving treatment for a physician-diagnosed AECOPD
  • Forced expired volume in the first second (FEV1) / Forced vital capacity (FVC) \< 0.7 (GOLD 1-4)
  • Ability to provide informed consent

Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
McGill University Health Centre
Coordinator of this site? Confirm its status
MontrealCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.